Novartis
Filter by Data Source:
| Contribute a News Item | Follow Novartis |
January 11, 2010
3 news releases published
January 08, 2010
2 patent assignments recorded
» CARBALLIDO HERRERA, JOSE M. et. al. → NOVARTIS AG» NORBERT KLEIN → NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO. KG
January 07, 2010
News release published
December 29, 2009
3 trademarks published for opposition
"The Access Sandoz Program", "Sandoz", "Afluzel"December 29, 2009
2 SEC filings submitted
» Form 6-K: Current report of foreign issuer» Form 6-K: Current report of foreign issuer
December 17, 2009
20 patent assignments recorded
» NOVARTIS ANIMAL HEALTH US, INC. → NOVARTIS AG» IAN BRUCE et. al. → NOVARTIS AG
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
» NEUROGEN CORPORATION → NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
December 17, 2009
3 patent applications published
|
US20090311288: IMIDAZOQUINOXALINE COMPOUNDS AS IMMUNOMODULATORS
The invention proyides novel compositions comprising imidazoquinoxaline compounds of formula (I) and analogs thereof. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. F... + 2 more... |
December 16, 2009
loading...
